Clin2
NCT07485283Possibly a fitRecruiting

Shingles vaccine for preventing heart problems and dementia

Cardiovascular DiseaseDementia

Treatments studied

Part of Brain & nervous system, Heart & circulation, Infections, Mental health clinical trials.

This trial tests whether a shingles vaccine can help prevent heart attacks, strokes, and dementia in older adults. If you are 65 or older and haven't had the shingles vaccine before, you may be able to join.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
162,000 people
Ages
65 years and older
Study type
Interventional

Who can take part

  • You are 65 years or older
  • You can understand Danish or English
  • You have not been diagnosed with dementia
  • You do not have a chronic inflammatory rheumatic disease that requires immunosuppressive therapy
  • You have never received a shingles vaccine

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07502560Recruiting· Phase 4
Shingles vaccine to prevent dementia in Finland

This study tests whether the shingles vaccine can reduce the risk of developing dementia in adults 76 and older living in Finland. You would get the vaccine and then researchers will follow your health records for up to several years to see if it protects your brain.

Espoo
NCT06903078Recruiting
Shingles and Dementia Risk Study

This study looks at whether the virus that causes shingles (herpes zoster) might increase the risk of dementia. Participants with a fresh shingles rash will give blood samples and attend several follow-up visits over one year.

Houston, Texas
NCT07481604Not yet recruiting· Phase 2
Shingles vaccine trial for adults 50 and older

This trial tests a new shingles vaccine to see if it's safe and helps the body build immunity. It is for healthy adults aged 50 and older who have not had shingles before.

Daegu, Daegu
NCT06137755Recruiting· Phase 1
Shingles vaccine study for healthy adults 50-65

This trial tests a new shingles vaccine in healthy adults aged 50 to 65. Shingles can cause a painful rash, and the vaccine aims to prevent it.

Seoul, Eunpyeong-gu
NCT07633197Enrolling by invitation· Phase 1
Testing a new shingles vaccine for adults over 40

This study tests a new vaccine to protect against shingles (herpes zoster), a painful skin infection that can affect people as they age. You would receive the vaccine and be monitored to see if it's safe and how your body responds.

Zhengzhou, Henan
NCT06932523Recruiting· Phase 1/Phase 2
Shingles vaccine study for healthy adults

This trial tests a new shingles vaccine for healthy adults 40 and older. It aims to see if the vaccine is safe and helps protect against shingles.

Wuhan, Hubei

Hear when a new Dementia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.